Tech Company Financing Transactions
M3 Biotechnology Funding Round
On 4/21/2017, M3 Biotechnology raised $10.1 million in investment from private investors.
Transaction Overview
Company Name
Announced On
4/21/2017
Transaction Type
Venture Equity
Amount
$10,073,475
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 34 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Mason Rd. Box 352141 300
Seattle, WA 98195
USA
Seattle, WA 98195
USA
Phone
Website
Email Address
Overview
M3 Biotechnology is a therapeutics company with a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases like Alzheimer's.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leen Kawas
Chief Financial Officer
Glenna Mileson
Browse more venture capital transactions:
Prev: 4/21/2017: Invertex venture capital transaction
Next: 4/21/2017: MediaHound venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs